Inhibition of hypothalamic neuropeptide Y gene expression by insulin
- PMID: 1597158
- DOI: 10.1210/endo.130.6.1597158
Inhibition of hypothalamic neuropeptide Y gene expression by insulin
Abstract
Insulin acts in the brain to suppress feeding, whereas neuropeptide Y (NPY) has the opposite effect. Since fasting lowers plasma insulin levels and increases hypothalamic synthesis of NPY, we proposed that insulin may inhibit hypothalamic NPY gene expression. To test this hypothesis, we used RIA and in situ hybridization histochemistry to determine if centrally administered insulin could reduce levels of both NPY and its messenger RNA (mRNA) in discreet hypothalamic regions during fasting. Three groups of Long-Evans rats were entered into a 72-h study protocol. One group was fed ad libitum during this period, while the others were fasted. Fed rats received intracerebroventricular (icv) injections of saline vehicle at 12-h intervals, whereas fasted groups received icv vehicle alone or with insulin (4 mU/12 h). In vehicle-only treated rats, fasting significantly increased expression of preproNPY mRNA in the arcuate nucleus to 179 +/- 20% of fed controls. Administration of icv insulin during fasting abolished this increase (99 +/- 14% of fed controls; P less than 0.05 vs. fasted, vehicle-treated rats). Central insulin administration during fasting also reduced immunoreactive NPY concentrations in samples punched from the paraventricular nucleus (PVN) (875 +/- 122 pg/punch) to levels below vehicle-only treated rats (1396 +/- 435 pg/punch; P less than 0.05), similar to free-feeding control values (814 +/- 170 pg/punch). By comparison, neither fasting nor central insulin administration altered NPY levels in four other hypothalamic regions (supraoptic, ventromedial, dorsomedial, and arcuate nuclei). Continuous icv insulin infusion at a lower dose (2 mU/day) produced a similar result during a shorter period (48 h) of food deprivation in Wistar rats. In this study, central insulin infusion also inhibited the fasting-related increase in arcuate preproNPY mRNA levels and did not affect plasma glucose or insulin levels. This suggests that insulin acts locally to inhibit hypothalamic NPY mRNA expression. We conclude that the increase of levels of NPY in the PVN and preproNPY mRNA in the arcuate nucleus during fasting are inhibited by icv insulin. Fasting, therefore, increases NPY biosynthesis along an arcuate nucleus-PVN pathway in the hypothalamus via a mechanism dependent on low insulin levels.
Similar articles
-
Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats.Endocrinology. 1991 May;128(5):2645-7. doi: 10.1210/endo-128-5-2645. Endocrinology. 1991. PMID: 2019270
-
Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling.Am J Physiol Endocrinol Metab. 2005 Dec;289(6):E1051-7. doi: 10.1152/ajpendo.00094.2005. Epub 2005 Jul 26. Am J Physiol Endocrinol Metab. 2005. PMID: 16046456
-
NPY-induced overfeeding suppresses hypothalamic NPY mRNA expression: potential roles of plasma insulin and leptin.Regul Pept. 1998 Sep 25;75-76:425-31. doi: 10.1016/s0167-0115(98)00098-6. Regul Pept. 1998. PMID: 9802439
-
Growth hormone inhibits its own secretion by acting on the hypothalamus through its receptors on neuropeptide Y neurons in the arcuate nucleus and somatostatin neurons in the periventricular nucleus.Endocr J. 1998 Apr;45 Suppl:S19-26. doi: 10.1507/endocrj.45.suppl_s19. Endocr J. 1998. PMID: 9790225 Review.
-
Role of dorsomedial hypothalamic neuropeptide Y in energy homeostasis.Peptides. 2007 Feb;28(2):352-6. doi: 10.1016/j.peptides.2006.07.030. Epub 2006 Dec 28. Peptides. 2007. PMID: 17196304 Review.
Cited by
-
Impaired hypothalamic Fto expression in response to fasting and glucose in obese mice.Nutr Diabetes. 2011 Oct 31;1(10):e19. doi: 10.1038/nutd.2011.15. Nutr Diabetes. 2011. PMID: 23154321 Free PMC article.
-
Neuroendocrine microRNAs linked to energy homeostasis: future therapeutic potential.Pharmacol Rep. 2022 Oct;74(5):774-789. doi: 10.1007/s43440-022-00409-5. Epub 2022 Sep 9. Pharmacol Rep. 2022. PMID: 36083576 Review.
-
Daniel Porte Jr., 13 August 1931-13 May 2023.Diabetes. 2024 Jan 1;73(1):5-10. doi: 10.2337/db23-0787. Diabetes. 2024. PMID: 38118001 Free PMC article. No abstract available.
-
Insulin inhibits neuropeptide Y gene expression in the arcuate nucleus through GABAergic systems.J Neurosci. 2005 Sep 21;25(38):8657-64. doi: 10.1523/JNEUROSCI.2739-05.2005. J Neurosci. 2005. PMID: 16177033 Free PMC article.
-
Energy regulatory signals and food reward.Pharmacol Biochem Behav. 2010 Nov;97(1):15-24. doi: 10.1016/j.pbb.2010.03.002. Epub 2010 Mar 15. Pharmacol Biochem Behav. 2010. PMID: 20230849 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous